Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Fehmann

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Zeitschrift Fur Gastroenterologie|March 1, 1993
[Isolation and sequencing of cDNA of the GLP-I receptor]H C Fehmann, R Göke, B Göke
European Journal of Clinical Investigation|April 1, 1991
Glucagon-like peptide-1(7-36) amide is a new incretin/enterogastrone candidateR Göke, H C Fehmann, B Göke
Metabolism: Clinical and Experimental|June 1, 1996
Functional active receptors for insulin-like growth factors-I (IGF-I) and IGF-II on insulin-, glucagon-, and somatostatin-producing cellsH C Fehmann, P Jehle, U Markus, et al.
Der Internist|April 1, 1995
[Incretin research in the development of new strategies of diabetes therapy]B Göke, R Göke, H C Fehmann, et al.
Transplantation Proceedings|October 1, 1987
Cyclosporine A in low doses induces functional and morphologic changes in rat pancreatic B cellsH C Fehmann, R Haverich, F Stöckmann, et al.
Zeitschrift Fur Gastroenterologie|July 1, 1990
Carbachol priming increases glucose- and glucagon-like peptide-1 (7-36)amide-, but not arginine-induced insulin secretion from the isolated perfused rat pancreasH C Fehmann, R Göke, B Göke, et al.
Experimental Cell Research|July 1, 1994
Expression, intracellular localization, and gene transcription regulation of the secretory protein 7B2 in endocrine pancreatic cell lines and human insulinomasR Gherzi, H C Fehmann, R Eissele, et al.
Diabetes|January 1, 1995
Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amideF Kolligs, H C Fehmann, R Göke, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1997
No apparent benefit of liquid formula diet in NIDDMH Printz, B Recke, H C Fehmann, et al.
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1996
Regulation of glucagon-like peptide-I receptor expression and transcription by the protein kinase C pathwayH C Fehmann, J Schweinfurth, J Jiang, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Zeitschrift Fur Gastroenterologie|March 1, 1993
[Isolation and sequencing of cDNA of the GLP-I receptor]H C Fehmann, R Göke, B Göke
European Journal of Clinical Investigation|April 1, 1991
Glucagon-like peptide-1(7-36) amide is a new incretin/enterogastrone candidateR Göke, H C Fehmann, B Göke
Metabolism: Clinical and Experimental|June 1, 1996
Functional active receptors for insulin-like growth factors-I (IGF-I) and IGF-II on insulin-, glucagon-, and somatostatin-producing cellsH C Fehmann, P Jehle, U Markus, et al.
Der Internist|April 1, 1995
[Incretin research in the development of new strategies of diabetes therapy]B Göke, R Göke, H C Fehmann, et al.
Transplantation Proceedings|October 1, 1987
Cyclosporine A in low doses induces functional and morphologic changes in rat pancreatic B cellsH C Fehmann, R Haverich, F Stöckmann, et al.
Zeitschrift Fur Gastroenterologie|July 1, 1990
Carbachol priming increases glucose- and glucagon-like peptide-1 (7-36)amide-, but not arginine-induced insulin secretion from the isolated perfused rat pancreasH C Fehmann, R Göke, B Göke, et al.
Experimental Cell Research|July 1, 1994
Expression, intracellular localization, and gene transcription regulation of the secretory protein 7B2 in endocrine pancreatic cell lines and human insulinomasR Gherzi, H C Fehmann, R Eissele, et al.
Diabetes|January 1, 1995
Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amideF Kolligs, H C Fehmann, R Göke, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1997
No apparent benefit of liquid formula diet in NIDDMH Printz, B Recke, H C Fehmann, et al.
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1996
Regulation of glucagon-like peptide-I receptor expression and transcription by the protein kinase C pathwayH C Fehmann, J Schweinfurth, J Jiang, et al.
Pageof 10